Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines

The use of heat shock protein 90 inhibitors like 17-allylamino-17-demethoxy-geldanamycin (17-AAG) has been recently introduced as an attractive anticancer therapy. It has been shown that 17-AAG may potentiate the inhibitory effects of some classical anticolorectal cancer (CRC) agents. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadian, Mahshid, Zeynali, Shima, Azarbaijani, Anahita Fathi, Khadem Ansari, Mohammad Hassan, Kheradmand, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691578/
https://www.ncbi.nlm.nih.gov/pubmed/29204180
http://dx.doi.org/10.4103/1735-5362.217432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691578/
https://www.ncbi.nlm.nih.gov/pubmed/29204180
http://dx.doi.org/10.4103/1735-5362.217432

Ejemplares similares